Cargando…
Short-Term Resveratrol Exposure Causes In Vitro and In Vivo Growth Inhibition and Apoptosis of Bladder Cancer Cells
Conventional adjuvant chemotherapies for bladder transitional cell carcinomas (TCCs) may cause strong systemic toxicity and local irritation. Non-toxic resveratrol inhibits TCC cell growth but its feasibility in clinical management of TCCs remains obscure. This study aimed to evaluate the safety and...
Autores principales: | Wu, Mo-Li, Li, Hong, Yu, Li-Jun, Chen, Xiao-Yan, Kong, Qing-You, Song, Xue, Shu, Xiao-Hong, Liu, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934942/ https://www.ncbi.nlm.nih.gov/pubmed/24587049 http://dx.doi.org/10.1371/journal.pone.0089806 |
Ejemplares similares
-
Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas
por: Song, Xue, et al.
Publicado: (2018) -
Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas
por: Xue, Song, et al.
Publicado: (2016) -
Metabolic Patterns and Biotransformation Activities of Resveratrol in Human Glioblastoma Cells: Relevance with Therapeutic Efficacies
por: Shu, Xiao-Hong, et al.
Publicado: (2011) -
Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells
por: Zheng, Xu, et al.
Publicado: (2018) -
Preventive Potential of Resveratrol in Carcinogen-Induced Rat Thyroid Tumorigenesis
por: Zheng, Xu, et al.
Publicado: (2018)